A Study of Veliparib in Combination With Carboplatin and Paclitaxel in Japanese Subjects With Solid Tumors

NCT01617928 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: veliparib (ABT-888)
DRUG: carboplatin
DRUG: paclitaxel

Sponsor

AbbVie (prior sponsor, Abbott)